All of the implicated kinases (AKT2, ROCK1, BARK/GRK, and PKA), predicted to phosphorylate GFAP at the modified sites, had been previously implicated in AD pathogenesis or progression [45,46,47,48,49,50,51,52,53]. This evidence concerns the gene GFAP and Alzheimer disease.